Rhythm Pharmaceuticals
RYTM54
$62.26arrow_drop_up0.24%$0.14
High Growth
RYTM54
$62.26
arrow_drop_up0.24%Performance History
| Key Stats | |
|---|---|
| Open | $61.39 |
| Prev. Close | $62.01 |
| EPS | -4.34 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 59.38 | 64.25 |
| 52 Week Range | 21.34 | 68.48 |
| Ratios | |
|---|---|
| EPS | -4.34 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Rhythm Pharmaceuticals (RYTM)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. David P. Meeker M.D.
- Headquarters
- Boston
- Employees
- 177
- Exchange
- NASDAQ
Keep an eye on Rhythm Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Rhythm Pharmaceuticals 's (RYTM) price per share?
The current price per share for Rhythm Pharmaceuticals (RYTM) is $62.27. The stock has seen a price change of $0.15 recently, indicating a 0.24% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Rhythm Pharmaceuticals (RYTM)?
For Rhythm Pharmaceuticals (RYTM), the 52-week high is $68.48, which is 9.97% from the current price. The 52-week low is $21.34, the current price is 191.79% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Rhythm Pharmaceuticals (RYTM) a growth stock?
Rhythm Pharmaceuticals (RYTM) has shown an average price growth of -1.65% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Rhythm Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Rhythm Pharmaceuticals (RYTM) stock price performance year to date (YTD)?
As of the latest data, Rhythm Pharmaceuticals (RYTM) has a year-to-date price change of 11.23%. Over the past month, the stock has experienced a price change of 5.13%. Over the last three months, the change has been 13.92%. Over the past six months, the figure is 3.89%. Looking at a longer horizon, the five-year price change stands at 209.49%.
help
Is Rhythm Pharmaceuticals (RYTM) a profitable company?
Rhythm Pharmaceuticals (RYTM) has a net income of -$260.6M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -98.63% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $130.13M, with a revenue growth rate of 68.06%, providing insight into the company's sales performance and growth. The gross profit is $116.76M. Operating income is noted at -$265.5M. Furthermore, the EBITDA is -$263.93M.
help
What is the market capitalization of Rhythm Pharmaceuticals (RYTM)?
Rhythm Pharmaceuticals (RYTM) has a market capitalization of $3.83B. The average daily trading volume is 62.01, indicating the stock's liquidity and investor engagement.